KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2016 - 2023)

Supernus Pharmaceuticals has reported Interest Coverage Ratio over the past 13 years, most recently at 19.33 for Q2 2023.

  • Quarterly Interest Coverage Ratio fell 408.31% to 19.33 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 14.94 through Mar 2024, down 300.91% year-over-year, with the annual reading at 2.18 for FY2023, 133.44% down from the prior year.
  • Interest Coverage Ratio was 19.33 for Q2 2023 at Supernus Pharmaceuticals, down from 3.44 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 21.54 in Q4 2022 and troughed at 19.33 in Q2 2023.
  • The 5-year median for Interest Coverage Ratio is 5.87 (2021), against an average of 4.58.
  • Year-over-year, Interest Coverage Ratio surged 1996.02% in 2022 and then tumbled 408.31% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 7.07 in 2019, then decreased by 0.17% to 7.05 in 2020, then tumbled by 85.43% to 1.03 in 2021, then surged by 1996.02% to 21.54 in 2022, then plummeted by 189.73% to 19.33 in 2023.
  • Per Business Quant, the three most recent readings for SUPN's Interest Coverage Ratio are 19.33 (Q2 2023), 3.44 (Q1 2023), and 21.54 (Q4 2022).